Goodwin Procter advised Captify Technologies on the deal. Captify, the Search Intelligence Platform for the open web, announced that SFW Capital Partners, a leading US-based private...
SFW Capital Partners’ Investment in Captify Technologies
Unified Women’s Healthcare’s Strategic Partnership with CCRM Fertility
Goodwin Procter advised TA Associates and CCRM Fertility on the deal. Unified Women’s Healthcare, a leading practice management platform in women’s healthcare backed by Altas Partners,...
Repligen Corporation’s Acquisition of Polymem S.A.
Goodwin Procter advised Repligen Corporation on the deal. Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced the acquisition of Polymem S.A., a leading...
Intellia Therapeutics’ $690 Million Underwritten Public Offering
Goodwin Procter advised Intellia Therapeutics on the deal. Intellia Therapeutics, Inc. (Nasdaq: NTLA) announced its $690 million underwritten public offering on the heels of releasing the first-ever...
Kriya Therapeutics’ $100 Million Series B Financing
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...
Nimbus Therapeutics’ $105 Million Private Financing Round
Goodwin Procter LLP advised Nimbus Therapeutics on the deal. Nimbus Therapeutics announced the closing of a $105 million private financing round which was led by BVF Partners...
Prime Medicine’s $315 Million Financing
Goodwin Procter advised Prime Medicine™ on the deal. Prime Medicine™ announced its launch and funding rounds totaling $315 million. Prime Medicine is a biotechnology company founded to...
GeneWerk’s Merger with Protagen Protein Services
Goodwin Procter advised GeneWerk on the deal. GeneWerk announced its merger with Protagen Protein Services. GeneWerk, an Ampersand portfolio company, is a cell and gene therapy testing...
ADVITOS’ €20 Million Series F Financing Round
Goodwin Procter advised CIC Capital Deutschland GmbH and Crédit Mutuel Innovation on the deal. ADVITOS GmbH, a Munich-based medical technology company, announced the completion of a EUR...
Circle’s Business Combination with Concord Acquisition Corp
Goodwin Procter and Matheson advised Circle on the deal. Arthur Cox and Greenberg Traurig advised Concord Acquisition Corp. Circle announced its definitive business combination agreement with Concord...
Origin.Bio’s US$15 Million Series Seed Financing Round
Goodwin Procter LLP advised Origin.Bio on the deal. Origin.Bio announced its US$15 million Series Seed Financing Round, led by EQT Ventures with participation from existing investor BlueYard...
Novo Holdings’ Investment in Availity
Goldman Sachs & Co. LLC acted as exclusive financial advisor, and Davis Polk & Wardwell LLP and Taft Stettinius & Hollister LLP acted as legal advisors...